# Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss

> **NCT02616172** · PHASE1,PHASE2 · SUSPENDED · sponsor: **James Baumgartner, MD** · enrollment: 10 (estimated)

## Conditions studied

- Sensorineural Hearing Loss

## Interventions

- **GENETIC:** Autologous Bone Marrow Infusion

## Key facts

- **NCT ID:** NCT02616172
- **Lead sponsor:** James Baumgartner, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2015-10
- **Primary completion:** 2022-09
- **Final completion:** 2022-09
- **Target enrollment:** 10 (ESTIMATED)
- **Why stopped:** Restructuring Cell Lab
- **Last updated:** 2022-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02616172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02616172, "Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02616172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*